1. Less PONV with morphine-6-glucuronide than with morphine

   Clinical study 19 January 2013 Pages: 1 - 1

2. One in four biologicals subject to safety actions postapproval

   News item 19 January 2013 Pages: 2 - 2

3. Recent use of proton-pump inhibitors (PPIs) appears to be associated with an increased risk of community-acquired pneumonia (CAP)

   Epidemiology clinical study 19 January 2013 Pages: 2 - 2

4. Use of antipsychotics is associated with a marked increase mortality following peptic ulcer perforation

   Clinical study 19 January 2013 Pages: 2 - 2

5. Rise in serious ADRs reported to US FDA

   News item 19 January 2013 Pages: 3 - 3

6. EMEA recommends suspending Acomplia

   News item 19 January 2013 Pages: 3 - 3

7. β-Blocker use for hypertension may increase CV risk, mortality

   Clinical study 19 January 2013 Pages: 3 - 3

8. Previous hormone-replacement therapy (HRT) and anastrozole treatment appear to be major risk factors for developing joint symptoms

   Case report 19 January 2013 Pages: 3 - 3

9. Adalimumab

   Case report 19 January 2013 Pages: 4 - 4

10. Adalimumab

    Case report 19 January 2013 Pages: 4 - 4

11. Atorvastatin

    Case report 19 January 2013 Pages: 4 - 5

12. Azathioprine

    Case report 19 January 2013 Pages: 5 - 5

13. Bevacizumab

    Case report 19 January 2013 Pages: 5 - 5

14. Balsalazide/mesalazine

    Case report 19 January 2013 Pages: 5 - 5

15. Azathioprine

    Case report 19 January 2013 Pages: 5 - 5

16. Botulinum toxin A

    Case report 19 January 2013 Pages: 6 - 6

17. Carbamazepine

    Case report 19 January 2013 Pages: 6 - 6

18. Capecitabine

    Case report 19 January 2013 Pages: 6 - 6

19. Cefuroxime axetil

    Case report 19 January 2013 Pages: 7 - 7

20. Carisoprodol abuse

    Case report 19 January 2013 Pages: 7 - 7

21. Cefoperazone/sulbactam

    Case report 19 January 2013 Pages: 7 - 7

22. Ciclosporin

    Case report 19 January 2013 Pages: 7 - 7

23. Clomipramine

    Case report 19 January 2013 Pages: 8 - 8

24. Cotrimoxazole

    Case report 19 January 2013 Pages: 8 - 8

25. Celecoxib

    Case report 19 January 2013 Pages: 8 - 8

26. Cyclophosphamide/methylprednisolone/prednisolone

    Case report 19 January 2013 Pages: 9 - 9

27. Dasatinib

    Case report 19 January 2013 Pages: 9 - 9

28. Dextromethorphan/escitalopram/sertraline interaction

    Case report 19 January 2013 Pages: 9 - 9

29. Dapsone

    Case report 19 January 2013 Pages: 9 - 9

30. Efalizumab

    Case report 19 January 2013 Pages: 10 - 10

31. Doxorubicin liposomal

    Case report 19 January 2013 Pages: 10 - 10

32. Doxycycline

    Case report 19 January 2013 Pages: 10 - 10

33. Etanercept

    Case report 19 January 2013 Pages: 11 - 11

34. Efalizumab

    Case report 19 January 2013 Pages: 11 - 11

35. Esomeprazole/omeprazole/sodium bicarbonate

    Case report 19 January 2013 Pages: 11 - 11

36. Etanercept

    Case report 19 January 2013 Pages: 12 - 12

37. Etanercept

    Case report 19 January 2013 Pages: 12 - 12

38. Ethinylestradiol

    Case report 19 January 2013 Pages: 12 - 12

39. Etanercept

    Case report 19 January 2013 Pages: 12 - 12

40. Herbal medicines

    Case report 19 January 2013 Pages: 13 - 13

41. Heparin

    Case report 19 January 2013 Pages: 13 - 13

42. Follitropin-α/menotropin

    Case report 19 January 2013 Pages: 13 - 13

43. Herbal medicines

    Case report 19 January 2013 Pages: 14 - 14

44. Imiquimod

    Case report 19 January 2013 Pages: 14 - 14

45. Herbal medicines

    Case report 19 January 2013 Pages: 14 - 14

46. Imatinib

    Case report 19 January 2013 Pages: 14 - 14

47. Immunosuppressants

    Case report 19 January 2013 Pages: 15 - 15

48. Immunosuppressants

    Case report 19 January 2013 Pages: 15 - 15

49. Infliximab

    Case report 19 January 2013 Pages: 15 - 16

50. Azathioprine/infliximab/prednisolone

    Case report 19 January 2013 Pages: 16 - 16